Default: Lancet Respiratory Medicine,The

ISSN: 2213-2619

Journal Home

Journal Guideline

Lancet Respiratory Medicine,The Q1 Unclaimed

Elsevier Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Lancet Respiratory Medicine,The is a journal indexed in SJR in Pulmonary and Respiratory Medicine with an H index of 197. It has an SJR impact factor of 6,788 and it has a best quartile of Q1. It has an SJR impact factor of 6,788.

Lancet Respiratory Medicine,The focuses its scope in these topics and keywords: pulmonary, chronic, randomised, obstructive, idiopathic, fibrosis, disease, finlanda, exacerbations, doubleblind, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Lancet Respiratory Medicine,The

6,788

SJR Impact factor

197

H Index

231

Total Docs (Last Year)

909

Total Docs (3 years)

4114

Total Refs

8335

Total Cites (3 years)

410

Citable Docs (3 years)

9.38

Cites/Doc (2 years)

17.81

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


pulmonary, chronic, randomised, obstructive, idiopathic, fibrosis, disease, finlanda, exacerbations, doubleblind, diagnosisoncedaily, degradation, cromoglicate, cough, formulation, girl, guidancethe, health, identify, indacaterol, indian, influenza, inhaled, copdlandmark, controlled, assessment, asthma, asthmachildhood, bedaquiline, biomarkers, blinded, burden, call, cessation, change, classification, cleaning, collagen, comprehensive, consultations,

FAQS